High dose melphalan for refractory myeloma—the M. D. Anderson experience
- 1 April 1988
- journal article
- clinical trial
- Published by Wiley in Hematological Oncology
- Vol. 6 (2), 167-172
- https://doi.org/10.1002/hon.2900060217
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myelomaBlood, 1987
- Multiple myeloma treated with high dose intravenous melphalanBritish Journal of Haematology, 1987
- Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group Study.Journal of Clinical Oncology, 1986
- High-Dose Glucocorticoid Treatment of Resistant MyelomaAnnals of Internal Medicine, 1986
- Ten-Year Survival in Multiple MyelomaArchives of Internal Medicine, 1985
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMAThe Lancet, 1983
- Progress in the treatment of plasma cell myeloma?Journal of Clinical Oncology, 1983
- Long-Term Survival in Multiple MyelomaNew England Journal of Medicine, 1983
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975